First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma

Eun Kyoung Jeon; Jihyoung Hong; Sook Hee Hong; Ji Young Kang; Gyeongsin Park; Myeong Im Ahn; Jun Young Lee; Jinhyoung Kang

doi:10.1111/ajco.12204

First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma

Eun Kyoung Jeon
, Jihyoung Hong
, Sook Hee Hong
, Ji Young Kang
, Gyeongsin Park
, Myeong Im Ahn
, Jun Young Lee
, Jinhyoung Kang

The Catholic University of Korea

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Anticancer agents can induce sarcoidosis. Interferon-alpha, which is used for the treatment of malignant melanoma and renal cell cancer, is one causative agent of sarcoidosis. However, there are few reports of interferon-alpha-induced sarcoidosis in patients with malignant melanoma. Clinically, it is important to consider the possibility of sarcoidosis in such patients because it could be easily regarded as a metastatic lesion due to underlying malignancy and given unnecessary treatment. Here, we report on the first case of interferon-alpha-induced sarcoidosis in an Asian melanoma patient.

Original language	English
Pages (from-to)	e347-e349
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	12
Issue number	2
DOIs	https://doi.org/10.1111/ajco.12204
State	Published - 1 Jun 2016

Bibliographical note

Publisher Copyright:
© 2014 Wiley Publishing Asia Pty Ltd

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/ajco.12204

Cite this

@article{de3e8f2215954737920555f8b6ffd2b4,

title = "First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma",

abstract = "Anticancer agents can induce sarcoidosis. Interferon-alpha, which is used for the treatment of malignant melanoma and renal cell cancer, is one causative agent of sarcoidosis. However, there are few reports of interferon-alpha-induced sarcoidosis in patients with malignant melanoma. Clinically, it is important to consider the possibility of sarcoidosis in such patients because it could be easily regarded as a metastatic lesion due to underlying malignancy and given unnecessary treatment. Here, we report on the first case of interferon-alpha-induced sarcoidosis in an Asian melanoma patient.",

author = "Jeon, \{Eun Kyoung\} and Jihyoung Hong and Hong, \{Sook Hee\} and Kang, \{Ji Young\} and Gyeongsin Park and Ahn, \{Myeong Im\} and Lee, \{Jun Young\} and Jinhyoung Kang",

note = "Publisher Copyright: {\textcopyright} 2014 Wiley Publishing Asia Pty Ltd",

year = "2016",

month = jun,

day = "1",

doi = "10.1111/ajco.12204",

language = "English",

volume = "12",

pages = "e347--e349",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma

AU - Jeon, Eun Kyoung

AU - Hong, Jihyoung

AU - Hong, Sook Hee

AU - Kang, Ji Young

AU - Park, Gyeongsin

AU - Ahn, Myeong Im

AU - Lee, Jun Young

AU - Kang, Jinhyoung

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Anticancer agents can induce sarcoidosis. Interferon-alpha, which is used for the treatment of malignant melanoma and renal cell cancer, is one causative agent of sarcoidosis. However, there are few reports of interferon-alpha-induced sarcoidosis in patients with malignant melanoma. Clinically, it is important to consider the possibility of sarcoidosis in such patients because it could be easily regarded as a metastatic lesion due to underlying malignancy and given unnecessary treatment. Here, we report on the first case of interferon-alpha-induced sarcoidosis in an Asian melanoma patient.

AB - Anticancer agents can induce sarcoidosis. Interferon-alpha, which is used for the treatment of malignant melanoma and renal cell cancer, is one causative agent of sarcoidosis. However, there are few reports of interferon-alpha-induced sarcoidosis in patients with malignant melanoma. Clinically, it is important to consider the possibility of sarcoidosis in such patients because it could be easily regarded as a metastatic lesion due to underlying malignancy and given unnecessary treatment. Here, we report on the first case of interferon-alpha-induced sarcoidosis in an Asian melanoma patient.

UR - https://www.scopus.com/pages/publications/85028273504

U2 - 10.1111/ajco.12204

DO - 10.1111/ajco.12204

M3 - Article

C2 - 24935527

AN - SCOPUS:85028273504

SN - 1743-7555

VL - 12

SP - e347-e349

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

IS - 2

ER -

First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this